Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation

被引:68
作者
Albert, MH
Liu, Y
Anasetti, C
Yu, XZ
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Univ Washington, Dept Med, Seattle, WA USA
关键词
Foxp3; regulatory T cells; GVHD; transplantation;
D O I
10.1002/eji.200526077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adoptive transfer of polyclonal CD4(+)CD25(+) regulatory T cells (Treg) can tolerize transplantation alloresponses. Treg are activated via their specific TCR, but the antigen specificity of wild-type Treg remains elusive, and therefore controlling potency and duration of Treg activity in the transplantation setting is still not feasible. In this study, we used murine graft-versus-host disease (GVHD) as a model system to show that antigen-specific Treg suppress the response of T effector cells to alloantigens in vitro and prevent GVHD in vivo. The suppressive potential of antigen-specific Treg was much greater than that of polyclonal Treg. To acquire large numbers of antigen-specific Treg, we transduced CD4(+)CD25(-) cells with foxp3, and found that these foxp3-induced Treg suppress alloresponses in vitro and prevent GVHD in vivo as effectively as naturally derived CD4(+)CD25(+) Treg. Furthermore, we used an antigen-specific CD4 Th1 clone as a source of foxp3-induced Treg after transduction with foxp3, and found those Treg to effectively prevent GVHD in an antigen-dependent manner. The findings of this study provide a basis for the concept that the onset and potency of the suppression by Treg can be regulated, and suggest a novel approach to enhance the feasibility and effectiveness of inducing tolerance by Treg as an adoptive immunotherapy in transplantation.
引用
收藏
页码:2598 / 2607
页数:10
相关论文
共 39 条
[1]   Haematopoietic cell transplantation as immunotherapy [J].
Appelbaum, FR .
NATURE, 2001, 411 (6835) :385-389
[2]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[3]  
Chai JG, 2002, EUR J IMMUNOL, V32, P2365, DOI 10.1002/1521-4141(200208)32:8<2365::AID-IMMU2365>3.0.CO
[4]  
2-2
[5]  
Chen W, 1998, J IMMUNOL, V161, P909
[6]  
Clark JG, 1998, J IMMUNOL, V161, P1913
[7]   Forkhead-box transcription factors and their role in the immune system [J].
Coffer, PJ ;
Burgering, BMT .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (11) :889-899
[8]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[9]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[10]  
ERGMANN J, 2005, BLOOD, V105, P2220